Drug Shortage Report for LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION

Last updated on 2024-10-03 History
Report ID 193838
Drug Identification Number 02489368
Brand name LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION
Common or Proper name LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) TIMOLOL LATANOPROST
Strength(s) 5MG 50MCG
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC
Packaging size 2.5mL
ATC code S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2023-06-26
Actual start date
Estimated end date
Actual end date 2024-10-01
Shortage status Resolved
Updated date 2024-10-03
Company comments Product to be discontinued.
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2024-10-03 French Compare
v8 2024-10-03 English Compare
v7 2024-10-02 English Compare
v6 2024-10-01 French Compare
v5 2024-10-01 English Compare
v4 2023-06-27 English Compare
v3 2023-06-06 French Compare
v2 2023-06-06 English Compare
v1 2023-06-06 English Compare

Showing 1 to 9 of 9